BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12718767)

  • 1. Retroviral transfer of donor MHC class I or MHC class II genes into recipient bone marrow cells can induce operational tolerance to alloantigens in vivo.
    Wong W; Billing JS; Stranford SA; Hyde K; Fry J; Morris PJ; Wood KJ
    Hum Gene Ther; 2003 Apr; 14(6):577-90. PubMed ID: 12718767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoviral transfer of a single donor-specific MHC class I gene to recipient bone marrow cells can induce specific immunological unresponsiveness in vivo.
    Fry JW; Morris PJ; Wood KJ
    Gene Ther; 2002 Feb; 9(3):220-6. PubMed ID: 11859426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syngeneic bone marrow transduced with a recombinant retroviral vector to express endoplasmic reticulum signal-sequence-deleted major histocompatibility complex class-I alloantigen can induce specific immunologic unresponsiveness in vivo.
    Spriewald BM; Billing JS; Jenkins S; Wheeler P; Steger U; Bushell A; Hyde K; Morris PJ; Wood KJ
    Transplantation; 2003 Feb; 75(4):537-41. PubMed ID: 12605123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syngeneic bone marrow expressing a single donor class I MHC molecule permits acceptance of a fully allogeneic cardiac allograft.
    Wong W; Morris PJ; Wood KJ
    Transplantation; 1996 Nov; 62(10):1462-8. PubMed ID: 8958273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression.
    Wong W; Morris PJ; Wood KJ
    Transplantation; 1997 May; 63(10):1490-4. PubMed ID: 9175815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral gene transfer of a donor class I MHC gene to recipient bone marrow cells induces tolerance to alloantigens in vivo.
    Wong W; Stranford SA; Morris PJ; Wood KJ
    Transplant Proc; 1997; 29(1-2):1130. PubMed ID: 9123231
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of allogeneic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: potential role of a veto mechanism.
    Martin PJ
    Blood; 1996 Aug; 88(3):962-9. PubMed ID: 8704255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recipient cells expressing single donor MHC locus products can substitute for donor-specific transfusion in the induction of transplantation tolerance when pretreatment is combined with anti-Cd4 monoclonal antibody. Evidence for a vital role of Cd4+ T cells in the induction of tolerance to class I molecules.
    Saitovitch D; Morris PJ; Wood KJ
    Transplantation; 1996 May; 61(10):1532-8. PubMed ID: 8633384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular MHC class II controls regulatory tolerance to allogeneic transplants.
    LeGuern C; Akiyama Y; Germana S; Tanaka K; Fernandez L; Iwamoto Y; Houser S; Benichou G
    J Immunol; 2010 Mar; 184(5):2394-400. PubMed ID: 20100928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus.
    Morelli AE; Antonysamy MA; Takayama T; Hackstein H; Chen Z; Qian S; Zurowski NB; Thomson AW
    J Immunol; 2000 Jul; 165(1):226-37. PubMed ID: 10861056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linked unresponsiveness: early cytokine gene expression profiles in cardiac allografts following pretreatment of recipients with bone marrow cells expressing donor MHC alloantigen.
    Spriewald BM; Billing JS; Ensminger SM; Morris PJ; Wood KJ
    Cytokine; 2002 Jul; 19(1):6-13. PubMed ID: 12200107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of T-cell tolerance to an MHC class I alloantigen by gene therapy.
    Bagley J; Tian C; Sachs DH; Iacomini J
    Blood; 2002 Jun; 99(12):4394-9. PubMed ID: 12036867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged survival of mouse skin allografts after transplantation of fetal liver cells transduced with hIL-10 gene.
    Sembeil R; Sanhadji K; Vivier G; Chargui J; Touraine JL
    Transpl Immunol; 2004; 13(1):1-8. PubMed ID: 15203122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purified hematopoietic stem cell grafts induce tolerance to alloantigens and can mediate positive and negative T cell selection.
    Shizuru JA; Weissman IL; Kernoff R; Masek M; Scheffold YC
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9555-60. PubMed ID: 10920206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of MHC class II in allogeneic bone marrow transplantation and chimerism-based solid organ tolerance in a rat model.
    Timrott K; Beetz O; Oldhafer F; Klempnauer J; Vondran FWR; Jäger MD
    PLoS One; 2020; 15(5):e0233497. PubMed ID: 32442182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of indefinite survival of fully allogeneic cardiac grafts and generation of regulatory cells by intratracheal delivery of alloantigens under blockade of the CD40 pathway.
    Uchida N; Shirasugi N; Akiyama Y; Matsumoto K; Shimazu M; Kitajima M; Hamano K; Aramaki O; Ikeda Y; Niimi M
    Transplantation; 2003 Mar; 75(6):878-84. PubMed ID: 12660518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of linked suppression in addition to the donor H-2 class I-specific unresponsiveness in recipient T cells by transfusing class I plus class II-disparate, but not class I alone-disparate, bone marrow cells.
    Muraoka S
    Cell Immunol; 1990 Jun; 128(1):261-76. PubMed ID: 1971530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific unresponsiveness to a retrovirally-transferred class I antigen is controlled through the helper pathway.
    Fraser CC; Sykes M; Lee RS; Sachs DH; LeGuern C
    J Immunol; 1995 Feb; 154(4):1587-95. PubMed ID: 7836744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.